Delivery Order SPE2DB22D1202-SPE2DB24FVDS8
Award Date
6/14/24
Potential Completion Date
6/17/24
Potential Value
$2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of ELIQUIS 2.5 MG TABLET 60S to the Defense Logistics Agency (DLA), a defense agency, by Amerisourcebergen Drug Corp's Corporate Office Division. The contract has a ceiling value of $1,900.08 and a completion date of May 24, 2024. It is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary...
This federal contract award is for the delivery of ELIQUIS 2.5 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,929.48 and was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is November 15, 2024. The contract is part of a larger Indefinite Delivery...
This federal contract award is for the delivery of ELIQUIS 2.5 MG TABLET 60S to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $7,353.52 and an ultimate completion date of December 18, 2024. It is a Delivery Order under a Firm Fixed Price contract type. The contract is not designated with a set-aside requirement, indicating open competition....
This federal contract award is for the delivery of ELIQUIS 2.5 MG TABLET 60S to the Defense Logistics Agency (DLA), a major defense agency. The fixed-price delivery order, valued at $7,600.32, was awarded to Amerisourcebergen Drug Corp, a large pharmaceutical distributor, on September 27, 2024. The contract has an ultimate completion date of September 30, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop Support Medical, which...
This federal contract award is for the delivery of ELIQUIS 2.5 MG TABLET 60S to the Defense Logistics Agency (DLA). The contract, valued at $3,931.20, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a period of performance through February 6, 2025 and is structured as a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside and was awarded under Amerisourcebergen's...
This federal contract award is for the delivery order of ELIQUIS 5 MG TABLET 60S to the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, through its Corporate Office division. The contract has a ceiling value of $36,979.93 and is a firm fixed-price delivery order with a completion date of July 3, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of ELIQUIS 5 MG TABLET 60S to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract has a ceiling value of $50,532.98 and is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 17, 2024. The contract was awarded without a...
This federal contract award is for the delivery of ELIQUIS 2.5 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $13,626.92 and is a firm fixed-price delivery order with an ultimate completion date of October 21, 2024. This contract is associated with a larger Indefinite Delivery...
This federal contract award is for the delivery of ELIQUIS 2.5 MG TABLET 60S to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on January 16, 2025 with a ceiling value of $1,474.20 and an ultimate completion date of January 17, 2025. The award is a delivery order contract, with a firm fixed price pricing type. The contract does not have a set-aside designation,...
This federal contract award is for the delivery of ELIQUIS 2.5 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $4,750.20, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 25, 2024, with a completion date of September 26, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation. Amerisourcebergen Drug Corp, through...